Transport Platform Synthesis for Drug Development
- Авторы: Stukalov Y.V.1, Grigor’eva E.Y.1, Kulakov V.N.2, Baryshnikov A.Y.1
-
Учреждения:
- N. N. Blokhin Russian Cancer Research Center
- A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
- Выпуск: Том 51, № 6 (2017)
- Страницы: 480-481
- Раздел: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/244661
- DOI: https://doi.org/10.1007/s11094-017-1637-9
- ID: 244661
Цитировать
Аннотация
Asynthetic scheme for a transport platform for the creation of new diagnostic and therapeutic antitumor drugs that was based on a dendrimer with a core of pentaerythritol tetraglycidyl ether (TGEPE) and dendra with diallylamine was developed. The transport platform was promising for designing targeted antitumor agents for magnetic resonance tomography and nuclear medicine.
Ключевые слова
Об авторах
Yu. Stukalov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Россия, 24 Kashirskoe Shosse, Moscow, 115478
E. Grigor’eva
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Россия, 24 Kashirskoe Shosse, Moscow, 115478
V. Kulakov
A. I. Burnazyan Federal Medical Biophysics Center, Federal Medico-Biological Agency of Russia
Email: chem@folium.ru
Россия, 46 Zhivopisnaya St, Moscow, 123182
A. Baryshnikov
N. N. Blokhin Russian Cancer Research Center
Email: chem@folium.ru
Россия, 24 Kashirskoe Shosse, Moscow, 115478
Дополнительные файлы
